SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
-0.58%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$300M
AUM Growth
-$202M
(-40%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-70.9%
Top 10 Holdings %
Top 10 Hldgs %
37.39%
Holding
273
New
28
Increased
51
Reduced
62
Closed
72
Top Buys
| 1 |
Alkermes
ALKS
|
$10.5M |
| 2 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$6.24M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$6.16M |
| 4 |
United Therapeutics
UTHR
|
$5.45M |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$5.01M |
Top Sells
| 1 |
Biogen
BIIB
|
$22.9M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$18.3M |
| 3 |
Viatris
VTRS
|
$15.2M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$15M |
| 5 |
Edwards Lifesciences
EW
|
$11.7M |
Sector Composition
| 1 | Healthcare | 63.58% |
| 2 | Technology | 2.74% |
| 3 | Consumer Staples | 0.59% |
| 4 | Industrials | 0.54% |
| 5 | Materials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NDRM
251
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| – | – |
-12,416
| Closed | -$257K |
|
|
RPTP
252
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| – | – |
0
| – | – |
|
|
RPRX
253
DELISTED
Repros Therapeutics Inc.
RPRX
| – | – |
0
| – | – |
|
|
ETRM
254
DELISTED
EnteroMedics Inc.
ETRM
| – | – |
-1,965
| Closed | -$536K |
|
255
Novavax
NVAX
$1.27B
| – | – |
-26,352
| Closed | -$3.73M |
|
|
APC
256
DELISTED
Anadarko Petroleum
APC
| – | – |
-102,300
| Closed | -$6.18M |
|
|
HZNP
257
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-164,658
| Closed | -$3.26M |
|
|
IPCI
258
DELISTED
Intellipharmaceuticals International Inc.
IPCI
| – | – |
0
| – | – |
|
|
TSRO
259
DELISTED
TESARO, Inc.
TSRO
| – | – |
-20,000
| Closed | -$802K |
|
260
Eledon Pharmaceuticals
ELDN
$156M
| – | – |
-4,039
| Closed | -$6.77M |
|
261
Exact Sciences
EXAS
$9.73B
| – | – |
-289,112
| Closed | -$5.2M |
|
262
Exelixis
EXEL
$10.1B
| – | – |
0
| – | – |
|
|
NVIV
263
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| – | – |
0
| – | – |
|